Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries, an Israel-based company that develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients, has launched Gianvi (Drospirenone and Ethinyl Estradiol) tablets, generic version of Bayer's Yaz tablets.
Subscribe to our email newsletter
YAZ is a progesterone and estrogen combination birth control pill. Yaz is used for preventing pregnancy.
Teva Pharma has claimed that, as the first company to file an ANDA containing a paragraph IV certification for this product, it has been awarded a 180-day period of marketing exclusivity.
In 2008, Teva’s subsidiary Barr Pharmaceuticals had entered into a supply and licensing agreement with Bayer. Under this agreement, Teva has the right to launch an authorized generic version of Yaz on July 1, 2011, or earlier in certain circumstances.